Companies
SU
NikkeiHealth Care· Japan

4506

Sumitomo Pharma

$2,204.00

+0.30%

Open $2,183.50·Prev $2,197.50

as of 17 Apr

ANALYSIS PENDING

Power Core

Structural analysis in progress

Published
UniverseNikkei 225
SectorHealth Care

Direction of Movement

---

ROC 200

+103.3%

4506

Sumitomo Pharma

$2,204.00

+0.30%

Open $2,183.50·Prev $2,197.50

as of 17 Apr

Overvalued by 19%

DCF Fair Value: $1,845.38

Analysis Coming Q3/Q4 2026

News

No recent news available.

mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.

Company Profile

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.